• SPX
  • $5,956.89
  • 0.14 %
  • $8.18
  • DJI
  • $44,209.61
  • 0.77 %
  • $339.25
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $18,969.01
  • -0.02 %
  • -$3.41
Mersana Therapeutics, Inc. (MRSN) Stock Price, News & Analysis

Mersana Therapeutics, Inc. (MRSN) Stock Price, News & Analysis

Currency in USD Disclaimer

$2.07

$0.09

(4.55%)

Day's range
$1.95
Day's range
$2.12
50-day range
$1.78
Day's range
$2.83
  • Country: US
  • ISIN: US59045L1061
52 wk range
$1.22
Day's range
$6.28
  • CEO: Dr. Martin H. Huber M.D.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -6.92
  • Piotroski Score 3.00
  • Grade Neutral
  • Symbol (MRSN)
  • Company Mersana Therapeutics, Inc.
  • Price $2.07
  • Changes Percentage (4.55%)
  • Change $0.09
  • Day Low $1.95
  • Day High $2.12
  • Year High $6.28

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $3.00
  • High Stock Price Target $3.00
  • Low Stock Price Target $3.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.12
  • Trailing P/E Ratio -1.91
  • Forward P/E Ratio -1.91
  • P/E Growth -1.91
  • Net Income $-171,670,000

Income Statement

Quarterly

Annual

Latest News of MRSN

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Mersana Therapeutics, Inc. Frequently Asked Questions

  • What were the earnings of MRSN in the last quarter?

    In the last quarter Mersana Therapeutics, Inc. earnings were on Wednesday, November, 13th. The Mersana Therapeutics, Inc. maker reported -$0.09 EPS for the quarter, beating analysts' consensus estimates of -$0.18 by $0.09.

  • What is the Mersana Therapeutics, Inc. stock price today?

    Today's price of Mersana Therapeutics, Inc. is $2.07 — it has increased by +4.55% in the past 24 hours. Watch Mersana Therapeutics, Inc. stock price performance more closely on the chart.

  • Does Mersana Therapeutics, Inc. release reports?

    Yes, you can track Mersana Therapeutics, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Mersana Therapeutics, Inc. stock forecast?

    Watch the Mersana Therapeutics, Inc. chart and read a more detailed Mersana Therapeutics, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Mersana Therapeutics, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Mersana Therapeutics, Inc. stock ticker.

  • How to buy Mersana Therapeutics, Inc. stocks?

    Like other stocks, MRSN shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Mersana Therapeutics, Inc.'s EBITDA?

    Mersana Therapeutics, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Mersana Therapeutics, Inc.’s financial statements.

  • What is the Mersana Therapeutics, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -4.6579839913, which equates to approximately -465.80%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Mersana Therapeutics, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Mersana Therapeutics, Inc.'s financials relevant news, and technical analysis. Mersana Therapeutics, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Mersana Therapeutics, Inc. stock currently indicates a “sell” signal. For more insights, review Mersana Therapeutics, Inc.’s technical analysis.

  • A revenue figure for Mersana Therapeutics, Inc. for its last quarter?

    Mersana Therapeutics, Inc. published it's last quarterly revenues at $12.60 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.